The in vitro C3d generating attribute of <scp>HLA</scp>‐specific antibodies can be used to stratify immune risk in <scp>HLA</scp> incompatible transplantation by predicting the clinical efficacy of desensitisation-Reference-Cited by-同舟云学术

The in vitro C3d generating attribute of HLA‐specific antibodies can be used to stratify immune risk in HLA incompatible transplantation by predicting the clinical efficacy of desensitisation

Published:2023-08-21 Issue:5 Volume:102 Page:607-608
ISSN:2059-2302
Container-title:HLA
language:en
Short-container-title:HLA

Author:

Daga Sunil¹^ORCID,Khovanova Natasha²,Babu Adarsh³,Krishnan Nithya⁴,Briggs David⁵

Affiliation:

1. Renal Unit, Leeds Teaching Hospital NHS Trust Leeds UK

2. School of Engineering University of Warwick Coventry UK

3. Renal Unit, Gloucestershire Hospitals NHS Foundation Trust Gloucester UK

4. Renal Unit, University Hospitals of Coventry and Warwickshire NHS Trust Birmingham UK

5. Histocompatibility & Immunogenetics Laboratory, NHS Blood Transplant Birmingham UK

Funder

University Hospitals Coventry and Warwickshire NHS Trust

Publisher

Wiley

Subject

Genetics,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tan.15197

Reference6 articles.

1. C3d‐binding assay for the detection of complement activating HLA antibodies: A useful tool for allocation to highly sensitised recipients in the post‐CDC era?

2. Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report

3. C3d‐positive donor‐specific antibodies have a role in pretransplant risk stratification of cross‐match‐positive HLA‐incompatible renal transplantation: United Kingdom multicentre study

4. Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)

5. Defining the lower and upper limits of immunological risk of HLA antibody incompatible kidney transplantation: Current state of the art and limitations